Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Net Margin (2016 - 2020)

Edesa Biotech's Net Margin history spans 8 years, with the latest figure at 835148.8% for Q3 2020.

  • For Q3 2020, Net Margin changed N/A year-over-year to 835148.8%; the TTM value through Jun 2021 reached 2766570.6%, down 276485086.0%, while the annual FY2020 figure was 1935.59%, N/A changed from the prior year.
  • Net Margin for Q3 2020 was 835148.8% at Edesa Biotech, down from 1605.46% in the prior quarter.
  • Across five years, Net Margin topped out at 716.41% in Q3 2018 and bottomed at 835148.8% in Q3 2020.
  • The 5-year median for Net Margin is 1605.46% (2020), against an average of 77796.59%.
  • The largest annual shift saw Net Margin crashed -4253765bps in 2017 before it surged 25935234bps in 2020.
  • A 5-year view of Net Margin shows it stood at 1047.31% in 2016, then crashed by -553bps to 6837.24% in 2017, then skyrocketed by 110bps to 716.41% in 2018, then crashed by -242bps to 1015.15% in 2019, then tumbled by -82168bps to 835148.8% in 2020.
  • Per Business Quant, the three most recent readings for EDSA's Net Margin are 835148.8% (Q3 2020), 1605.46% (Q2 2020), and 1347.89% (Q1 2020).